Siva B. Mohan, MD, FACC, FSCAI, President
Dr. Siva Mohan, a native of Atlanta, is a healthcare entrepreneur and physician. He currently
practices interventional cardiology as faculty of Emory University School of Medicine. He
completed his post-secondary education at the University of Washington (Seattle) and Emory
University (Atlanta, GA). He completed his general cardiology fellowship at the University of
North Carolina at Chapel Hill, where he later received his fellowship training in coronary and
peripheral interventions. He is board-certified in Internal Medicine, Cardiology, and
Currently, Dr. Mohan is co-founder and president of RazorMetrics. As an entrepreneur, Dr.
Mohan was a principal in Health Point Partners, a population health company (Sarasota, FL). He
raised $8mm for the venture. After one year, he assisted in the sale of the Medicare Advantage
segment (BeHealthy) to Alignment Healthcare. Dr. Mohan has been an advisor to several
healthcare venture capital firms over the last ten years, including Hatteras Venture Partners
(Durham, NC). Prior to RazorMetrics, he was the chief medical officer for ePatientFinder, which
was acquired 5/18. Dr. Mohan is a graduate of Leadership Atlanta (class of 2013) and was also
awarded Atlanta Business Chronicle’s Top 40 under 40. He currently sits on the boards of Emory
Healthcare and the American Heart Association (SE chapter).
Dr. Mohan has distinguished himself in receiving many academic, professional, and leadership
awards. In addition to being well-published in peer-reviewed academic journals and textbooks,
he has also spearheaded the formation of the Southern Heart Research Institute, where
the academic clinical research is the mission. Beyond his strong commitment to clinical practice, he
holds advisory/investigator positions with several multinational medical device and
pharmaceutical companies where he has also served as a consultant. He is a member/fellow of
the American College of Cardiology, American Heart Association, Society of Coronary
Angiography and Intervention, and European Society of Cardiology.